4 completed. 2 Not applicable, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
Follow SET protein, human: new trials by email Literature Review of SET protein, human trials Research Report on SET protein, human
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Behavioural and Physiological Measures of Young Students With Dyslexia Set For Variability, Current Best Practices - EEG | Not applicable | Completed | McGill University | 30 | 2022-10-01 | 2025-05-21 |
| Speech Entrainment for Aphasia Recovery SET (Speech Entrainment Therapy) 3 weeks, SET (Speech Entrainment Therapy) 4.5 weeks, SET (Speech Entrainment Therapy) 6 weeks - Aphasia, Aphasia Non Fluent | Phase 2 | Completed | Medical University of South Carolina | 80 | 2020-08-21 | 2025-11-14 |
| A Study of Psilocybin for Major Depressive Disorder (MDD) Psilocybin, Niacin, Set and Setting (SaS) Protocol - Depressive Disorder, Major | Phase 2 | Completed | Usona Institute | 347 | 2020-01-23 | 2026-04-22 |
| Slow Expiratory Technique to Improve Alimentation in Children With Bronchiolitis Chest physiotherapy with SET, Standard Treatment - Acute Viral Bronchiolitis | Not applicable | Completed | Groupe Hospitalier du Havre | 42 | 2019-01-02 | 2022-12-09 |
Aphasia (1) · Aphasia, Broca (1) · Depression (1) · Depressive Disorder, Major (1) · Dyslexia (1) · Dyspnea (1) · Stroke (1)
Groupe Hospitalier du Havre (1) · McGill University (1) · Medical University of South Carolina (1) · Usona Institute (1)
United States (2) · Canada (1) · France (1)
Charles Raison, MD (1) · Leonardo Bonilha, MD, PhD (1) · Pascal Le Roux, MD (1)
PMID 33902087, PMID 33993135, PMID 37010196, PMID 37651119, PMID 39334411
U01DC017521 (1)